Cingulate Inc.
CING CINGWCIK 0001862150 · Pharmaceutical Preparations · Nasdaq, Nasdaq
- Cingulate Inc. (until 2026-06-16)
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$25.49M
−35.6% YoY
Q1 May 2026
EPS Diluted (TTM)
−$4.45
+59.1% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$24.03M
Q1 May 2026
Cash
$25.89M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
13.28M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.